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Treatment of severe arterial hypertension by atenolol. P. Barjon,
J. Fourcade, A Mimran, and A Seurot. Service de Médecine D,
Montpellier. Atenolol, a new cardioselective beta-blocker, was
used at a dose of 100 to 300 mg/day for the treatment of severe (8
cases) or malignant (8 cases) arterial hypertension in adults. Mild
or advanced renal failure was present in all but two patients.
Hypertension was suspected to be related to a renovascular or a
parenchymatous lesion in 7 cases. Other drugs were associated with
atenolol in 12 subjects, but the sole effects of atenolol could be
evaluated in 15 cases. This treatment was generally well tolerated.
Atenolol was highly effective to reduce or to normalize in a few
days the systolic and diastolic blood pressures in 12 subjects. A
slight decrease of the renal function was observed, but the treat-
ment never had to be discontinued. No clear relationship was
observed between the magnitude of the antihypertensive effect and
the reduction in heart rate, the initial plasma renin activity, or the
fall of renin activity under treatment. These results contrast with
other reports and suggest that the status of the renin-angiotensin
system and its modification by beta-blocker drugs are only part of
the determinants of the antihypertensive response in this group of
patients.
An attempt to classify renal segmental hypoplasia. M. Bringoif
M. Leski, and Chatelanat. Hôpital Cantonal de Genève. For many
years renal segmental hypoplasia has been described as a clinical
and morphologic entity. It is characterized by some clinical symp-
toms, hypertension in children, radiologic signs, localized depres-
sion of the renal cortex with levelling of clublike calyces, and
specific morphologic features. Moreover, experimental studies re-
lating to renal segmental lesions induced by intrarenal reflux may
have contributed to increasing the nosologic complexity of renal
segmental hypoplasia. Reviewing autopsy and rrephrectomy data
from adults and children in the Department of Pathology of Gen-
eva, we suggest classifying segmental hypoplasia into two forms: 1)
Primary segmental cortico-medullary hypoplasia. Arciform vessels
are separated from the renal capsule by only a few normal, atro-
phic or dilated tubules, and rarely by some normal or hyalinized
glomeruli. Arterioles with or without moderate endofibrosis are
not very numerous, and their arrangement is normal or slightly
tortuous. The medulla is very badly developed, occasionally with
cystic transformation of the tubules. 2) Secondary segmental cor-
tico-medullary hypoplasia. The shrunken cortex contains very nu-
merous, mostly hyalinized, glomeruli. Arteries are tortuous and
their lumen is narrowed by extensive endofibrosis. Tubules are
collapsed or cystic. An inflammatory infiltration with strong lym-
phocytic predominance is often seen in the interstitium. The me-
dulla also becomes thinner. The juxtacortical portion has a cica-
tricial aspect. The internal zone contains some dilated or undilated
tubular remnants. Juxtaposition and/or intrication of the two
forms and their differential diagnosis are discussed.
Individual renal clearance measurements in man using the early
part of 1311-hippuran renogram. J. Chanard, J. Assailly, F. Russo-
Marie, C. Bader, P. Garderet, and J. L. Funck-Brentano. Déparle-
men! de Nèphrologie, Hôpital Necker, Paris, France. A quantitative
measurement of individual renal function is proposed, taking into
account the relationship between the early part of the "I-hippuran
renogram as corrected for blood background and the blood in-
tegral measured over the subclavicular area. This relationship can
be expressed as individual clearance for each kidney. However, a
prior injection of "I-hippuran and "I-albumin is required to
balance detection efficiency of the two kidney probes and calibra-
tion of the blood activity curve. Individual renal clearances were
calculated from the total '311-hippuran clearance value measured
by a simplified method without urine collection. In seven control
subjects, clearances were 51.2 1.3 and 48.3 + 1.4% of total
clearance for right and life kidneys respectively. In four unine-
phrectomized patients, a precision of 5% in calculating individual
clearance was estimated from data recorded at the level of the
remaining kidney. In eight patients with functional asymmetry, re-
sults were compared with "7HgCI2 renal fixation. A correlation
coefficient of 0.95 was found. The method we propose seems valu-
able for clinical investigation, allowing repetitive measurements.
Bromine content in the blood of patients with renal failure. R.
Cornelis, S. Ringoir, J. Hoste. Department of Nephrology and In-
stitute for Nuclear Sciences, University of Ghent, Ghent, Belgium.
Blood bromine (Br) content was determined by neutron activation
analysis. Normal blood Br ranges between 1.2 and 2.5kg of Br/mi.
Out of 20 patients with moderate renal failure, 8 had a normal
blood Br content and 12 had values from 3.15 to 8.85ig/ml. Five
patients with severe renal failure had a blood Br concentration of
166, 56.4, 120, 22.6, and 26.0kg/mI, respectively. There is no
correlation with serum creatinine, urea, or Cl. With peritoneal
dialysis the blood Br is normalized. Hemodialysis is very active for
the removal of Br. In 10 patients on chronic hemodialysis, the
blood Br was below normal. Intake of Br-containing drugs was not
present in the patients on the study. The significance of these
findings is discussed in relation to the neurological symptoms.
Treatment of water retention by demeclocycline in liver cirrhosis.
A. De Troyer, D. Zegers de Beyl, andf. C. Demanet. Department of
Internal Medicine, Saint-Pierre University Hospital, Brussels, Bel-
gium. Demeclocycline (DMC), an established inhibitor of vasopres-
sin (ADH) action, was tested to treat fluid retention in 8 patients
with cirrhosis and overt fluid retention, in whom no diuresis had
occurred under bed rest and dietary sodium restriction (10 to 20
mEq/24 hr). In the patients whose urine osmolality was initially
higher than serum osmolality, oral administration of DMC (1200
mg a day) during 5 to 12 days induced an overt decrease in urine
osmolality with positivation of free water clearance and a gradual
increase in water diuresis. An unexpected increase in urinary so-
dium excretion was also observed, resulting in a negative sodium
balance (up to 100 mEq/day), and marked weight loss. Simultane-
ously, a moderate elevation of blood urea and creatinine was
noted, as well as a decrease in creatinine clearance. No change was
noted in serum electrolyte levels and in hepatic function tests.
With cessation of the drug, all parameters returned to baseline
values. In those patients whose basal urine osmolality was lower
than serum osmolality, no change appeared under DMC adminis-
tration. From these data, it appears that this ADH-inhibiting drug
may be useful in the treatment of edematous states, especially in
the patients with high urine osmolality.
Congestive cardiomyopathy in uremia: Hemodynamic and angio-
graphic studies. T. DrOeke, C. Le Pailleur, B. Meilhac, C. Cou-
toudis, J. Zingraff, P. Jun gers, J. Di Mat teo, J. Crosnier. Dèparte-
men! c/c Thèrapeutique Néphrologique et Clinique Cardiologique,
Hbpital Necker, Paris, France. The existence of a uremic cardiomy-
opathy remains highly controversial. Twelve out of 450 chronic
hemodialysis patients (CHD pts) presented with signs and symp-
toms of congestive heart failure of obscure origin. There was no
evidence of coronary heart disease, endocarditis, pericardial effu-
sion, chronic fluid overload, severe anemia, or chronic electrolyte
disturbances. Five out of the 12 CHD pts were selected for left
cardiac catheterization because of the severity of their heart failure.
The diagnosis of congestive cardiomyopathy was established by
angiocardiographic and hemodynamic studies showing a signifi-
cant (P < 0.01) increase in left ventricular end-diastolic volume to
190 + 21 (sEM) mI/m' when compared to normal values obtained
in 12 patients without uremia (71 4 ml/m'). Mean velocity of
myocardial fiber shortening (mean VCF) was found to be signifi-
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cantly decreased (P < 0.01) to 0.44 0.11 length per second
(control 1.25 0.09 length per second), as was the index of
normalized rigidity (k = 0.017 + 0.001 vs. 0.041 0.002). Three
out of the five CHD pts presented the complete picture of the
disease. The two others also had important ventricular dilatation
and decreased index of normalized rigidity but normal ejection
fraction and only moderately decreased myocardial contractility
indices. This suggests a possible primary involvement of norma-
lized heart muscle rigidity followed by secondary alteration in
myoeardial contractility. The study indicates that a congestive
cardiomyopathy, possibly related with the uremic state, may de-
velop in patients undergoing intermittent hemodialysis.
The behaviour of gentamicin and sisomicin in the kidney. J. Fabre,
Madeleine Rudhardi, P. Blanchard. Policlinique de Mèdecine, Dê-
parteinent de Médecine, Geneva, Switzerland. To study the behav-
iour of aminoglycoside antibiotics in the kidney, groups of 6 rats
received a single 4 mg/kg i.p. injection of gentamicin and were
sacrificed from 30 mm to 28 days later. Gentamicin concentrations
(bioassay) decreased rapidly in the serum, lung, and other tissues.
Only a trace remained at 6 hours. The situation was totally differ-
ent for the kidney. Up to 6 hours, concentrations in the cortex
increased, with a maximum of I 23ig/ml, 20 times higher than the
peak value in the serum, then decreased very slowly to 80, 22, and 7
isg/ml, 2, 14, and 28 days, respectively, after injection. Concentra-
tions in the medulla were lower than in the cortex but also showed
an accumulation and persistence. Similar results were observed
with sisomicin. In another experiment, daily injections of gen-
tamicin or sisomicin during 7 days demonstrated that the concen-
trations of both antibiotics 6 hours after the last injection were
nearly 3 times higher in the cortex and twice as high in the medulla
than afte, a single injection. These data are in contrast with the
behaviour of doxycycline, whose concentrations show a parallel
decrease in the serum and in the tissues, including the renal cortex
and medulla. Ampicillin showed only a minimal persistence in the
kidney (half-life:27 mm in the serum, 32 mm in the cortex, 54 mm
in the medulla). The curious pharmacokinetics of gentamicin and
sisomicin explains why the nephrotoxicity of these aminoglyco-
sides involves chiefly the cortex, increases with the length of the
treatment, and can persist for several weeks after the last injection.
The very high concentration of aminoglycosides in the cortex
emphasizes the great interest of the observations made by Fillastre
et al on the changes in the respiratory processes of the organdIes
in vitro at similar antibiotic concentrations.
Inhibitor of sodium transport in the normal human and in patients
with a Conn syndrome. H. Favre. Division of Nêphrologie, Départe-
men! de Médecine, Hbpital Cantonal, Geneva. The urine of chroni-
cally expanded normal dogs contains a factor that produces a
natriuresis in the rat. The present studies represent an effort to
detect the same inhibitor in human urine. In five normal subjects,
sodium intake was maintained at less than 10 and more than 300
mEq a day over 10 days. In addition, two patients with a Conn
syndrome were studied on a 120 mEq of sodium per day diet before
and after operation. The same gel filtration fraction containing the
inhibitor found in the dog was tested in urine from all the groups
using a rat bioassay. The fraction from subjects on more than 300
mEq of sodium consistently induced natriuresis in the rat (P <
0.001); in contrast the fraction from the same subjects when receiv-
ing less than 10 mEq of sodium had no significant effect. For patients
with a Conn syndrome, a clear natriuretic effect was found with a
fraction obtained before the operation. On the same diet, identical
fraction collected after the operation had no effect in the rat. Thus,
the natriuretie factor previously demonstrated in the dog receiving
a large load of sodium with or without 9 a fluorocortisone has
been found in human urine, and the presence of the inhibitor
correlates with the requirements for maintaining external sodium
balance.
Comparison of la-hydroxycholecalciferol and 25-hydroxychole-
calciferol in the treatment of renal osteodystrophy. A. Fournier,
P. Bordier, J. Guérjs, P. Marie, J. L. Sebert, J. Bedrossian, and
H. F. Dc Luca. CH U A miens, France, Hôpital Lariboisibre Paris,
Hbpital Broussais, Paris, University of Wisconsin, Madison. la-OH
D3 was given at mean daily doses of 2ig to ten uremic patients
(eight on chronic hemodialysis) for 2 to 6 months and 25-OH D3 at
mean daily doses of l00g to nine ureniic patients (eight on chronic
hemodialysis) for I to 12 months. Transilial bone biopsies were
made before and at the end of drug administration, and quan-
titatively evaluated. Plasma levels of calcium (P), phosphate
(P), immunoreactive parathyroid hormone (PIpTIl) and serum
alkaline phosphatase (Alk. Pase) were monitored weekly or fort-
nightly. The compounds appeared equally hypercalcemic, but the
effect appeared and disappeared more rapidly with la-OH D3 (2
weeks/4 days) than with 25-OH D3 (8 weeks/4 weeks). la-OH D3
induced greater increase in P0 and in P x Ppo4. Percentage of
decrease of PPTH was of the same magnitude with both drugs and
was not correlated to P increase. Osteoclast count and active
resorption surface decreased more with la-OH D3. Parallel de-
crease of Alk.Pase and osteoblastic surface was observed with
la-OH D3, whereas with 25-OH D3 these two parameters increased
for I to 4 months and decreased only at 6 months. In patients
whose doses of phosphate binders and duration of dialysis were
unchanged, calcification front (CF) changes were negatively corre-
lated with changes in P0 x Pp0. In this group CF increase was
greater, whereas P, x P0, increase was smaller with 25-OH D3
than with la-OH D. In the group with changes in duration of
dialysis or in doses of phosphate binders, an opposite (positive)
correlation was found. This suggests that increase in Pca X Ppo
favors the osteoid mineralization induced by vitamin D metabolite
but does not seem to be the primary event. Initiation of osteoid
mineralization by direct action of the metabolite on bone, stronger
with 25-OH D3 than with In-OH D, seems to be this primary
event. It is concluded that the drug of choice for treatment of renal
osteomalacia maybe 25-OH D3, and la-OH D3 (or 1.25 (OH)2 D3)
for the treatment of osteitis fibrosa.
Inhibition of complement-dependent lymphocyte rosette formation
by sera of patients with glomerulonephritis. J. C. Gluck man, H.
Beaufils, F. Sanchez. Department of Nephrology and INSERM
U.27, Groupe Hospitalier Pitib-SalpétrThre, Paris, France. Recently,
it has been demonstrated that activated C3 products might bind to
lymphocyte C3 receptors and inhibit subsequent complement-de-
pendent lymphocyte rosette formation. Therefore, sera from 80
patients with various types of glomerulonephritis have been tested
in a complement-dependent rosette inhibition assay, using normal
donors' lymphocytes as reacting cells. Control subjects consisted of
12 healthy donors and 15 patients with miscellaneous renal disease.
Most sera of membranoproliferative glomerulonephritis and of
systemic lupus, and 67% sera focal glomerulosclerosis patients
significantly inhibited rosette formation. Only 15 to 40% sera of
patients with other types of glomerulonephritis were inhibitory.
No effect was observed with sera of five adults with minimal-
change nephrotic syndrome. Serum inhibiting activity usually corre-
lated with serum C3 level (P < 0.0005), although inhibition could
be observed with normal C3. These results extend previous find-
ings and suggest that the complement-dependent rosette inhibition
assay can be used routinely to detect serum activated complement
components either free or bound to immune complexes.
Origin of edemas during human glomerulonephritis. J. P. Godon.
Université de Liege. Département de Clinique et de Sbméiologie
Medicates, Secteur de Néphrologie, Liege, Belgique. Our previous
works have demonstrated that the sodium retention, observed
during the autologous stage of experimental glomerulonephritis(G.N.) was due to the disappearance of a natriuretic factor of
45.000 mol. wt. We have proved the renal origin of this factor; it is
able, itself only, to restore in nephritic animals, the ability to
excrete adequately a saline load. The patients, with membrano-
proliferative GN or nephrotic syndrome (with minimal changes)
are, as the glomerulonephritic rats, unable to excrete a saline load.
The natriuretic factor, described in normal animals, is also pres-
ent in plasma of salt-loaded healthy subjects, whereas it is absent in
patients with membrano-proliferative GN, nephrotic syndrome
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(minimal changes) before treatment or during the oliguric phase of
acute glomerulonephritis. This factor reappears during the recov-
ery phase of nephrotic syndrome or acute glomerulonephritis. If,
when injected to the glomerulonephritic animals, this natriuretic
factor induces a complete recovery of normal natriuresis, its dis-
appearance is certainly the origin of sodium retention during the
experimental glomerulonephritis. The observations being com-
parable in men and animals, we can conclude that the edemas of
human glomerulonephritis are due to the absence of such a factor
of renal origin.
Labile hypertension and prostaglandins. A. Hornych, M. Safar, G.
London, V. Weiss, J. Bariéty, and P. Milliez. Centre de Recherches
sur 1' Hypertension A rtérielle, U-28 INSERM, Hbpital Broussais,
Paris. We have been interested in the role of prostaglandins in the
pathophysiology of labile hypertension. The prostaglandins (PGs)
A,B,E2, and F alfa have been measured by radioimmunoassay
method in peripheral plasma of 23 control subjects (normotensive
healthy volunteers) and 13 labile hypertensive patients (PGB,E2, F
alfa have been measured only in 5 of them). Cardiac output and
total peripheral resistance (TPR) have been measured in II
patients. Results: I) Control normotensive subjects. Systolic arterial
blood pressure (BP): 118 2 mm Hg; diastolic BP: 75 I mm Hg.
Cardiac index (Cl) and TPR of 40 control subjects were: Cl, 3374
105 mI/mm; TPR, 2173 72 dynes. sec. cm5 m2; PGAI eq, 109
+ IS pg/mi: PGB1 eq., 189 14 pg/mI; PGE2, 5.5 + 0.8 pg/mI;
PGF aifa, 17.2 3.3 pg/mI (mean value + saM). 2) Labile hyper-
tensive subjects. Systolic BP: 133 3mm Hg (P < 0.005), diastolic
BP: 83 + 3 mm Hg (P <0.025); Cl, 3950 + 170 mI/mm (P < 0.02);
TPR, 2037 + 78 dynes. sec. cm-5 m2 (NS); PGA1 eq., 259 + 40
pg/mi (P < 0.001); PGB1 eq., 254 + 39 pg/mI (NS); PGE2, 40.0 +
12 pg/mI (P < 0.001); PGF alfa, 29.0 7.5 pg/mI (NS). Labile
hypertensive subjects differ from control subjects by the significant
increase of blood pressure, cardiac output, PGA, and PGE. The
increase of PGA and PGE represents, presumably, a secondary
antihypertensive mechanism responsible for the decrease in total
peripheral resistance.
Nail patella syndrome with renal disease. C. Huriet, Mme M.
Kessler, F. Maurice, B. Guitlienne, G. Rauber. Nancy, France. This
hereditary syndrome is characterized by abnormalities of finger-
nails and bone dysplasia in elbows, patella, and pelvis. The authors
report a case of nail patella syndrome with renal disease. Genetic
transmission appears dominant. Clinical manifestations include
proteinuria and an evolution towards progressive renal failure.
Histological lesions involve primarily the glomerular basement
membrane.
Membranous glomerulonephritis (MGN) with extra-renal dis-
orders in children C, Kleinknecht, M. Levy, M. F. Gagnadoux, R.
Habib. Hbpital des Enfants-Malades, Paris, France. Extrarenal dis-
orders coexisted with the nephropathy in 30 of 85 children with
MGN. In 20 of these, the responsibility of a definite antigen (Ag)
can be suspected: I) hepatitis B Ag (HBAg) was present in 8
children; 3 of them presented with acute hepatitis and recovered
from their nephropathy despite the persistence of HBAg; 2) sys-
temic lupus erythematosus (2 cases); 3) sickle cell disease (1 case)
or trait (3 cases); 4) congenital syphilis in one infant who recovered
after penicillin therapy; 5) penicillamine therapy for Wilson's
disease (I case); 6) a streptococcal hypersensitivity may be sus-
pected in four patients who presented with scarlet fever (3 cases) or
rheumatic fever (I case). The associated findings in the ten remain-
ing patients suggested a multiorgan involvement due to circulating
immune complexes of unknown origin: thrombopenic purpura (1
case); arthralgias, myalgias, fever and purpura coexisting with the
onset of MGN, 5 years after remission of a myelomonocytic leu-
kemia (1 case); proximal tubular dysfunction (2 cases) with pres-
ence of antitubular and antilung BM antibodies in the child who
underwent immunopathologic investigations; polyarthralgias with
or without fever, and skin rashes (6 cases). Immunofluorescent
studies showed the presence of lgG in 17/17 patients studied, of C3
in 11/17, of C4 in 3/10, and of Ciq in 5/10. Plasma C3 was normal.
Plasma C13, C4, and C3PA were significantly lower than in controls
(mean values: 75% vs. 99%, 29 mg/lOU ml vs. 43 mg/lOO ml, 18
mg/ 100 ml vs. 26 mg/IOU ml). The immunopathologic findings did
not differ significantly from those observed in the apparently iso-
lated MGN.
Renal transplantation and immunological abnormalities in five
adult patients with thrombotic microangiopathy (TM A). 0.
Kourilsky, J. D. Sraer, M. Arias-Rodriguez, M. D. Smith, P. J.
Verroust, A. Meyrier, H. E. Kuntziger, A. Kanfer. V. Nessim. L.
Morel-Maroger. G. Richet. Service de Nèphrologie and INSERM
U64, Hbpital Tenon, Paris, France. Renal transplantation was per-
formed in five adult patients with TMA, three of whom had had a
bilateral nephrectomy prior to transplantation. Four patients re-
ceived a cadaver kidney and one a kidney from a living donor. The
graft remained functional in three patients, 6 yr, 17 and 11 months
after transplantation. One patient developed a rapid thrombosis of
the renal artery, and one patient died from infection four months
after the transplantation. There was no clinical or histologic evi-
dence of recurrence of TMA after transplantation. Immunological
investigations were performed in four out of five patients before
transplantation. CIq and C3 levels were low in two patients. Serum
C3-splitting activity and circulating immune complexes were pres-
ent in all four patients and remained unchanged on hemodialysis
(I case) and/or after bilateral nephrectomy (2 cases). Complement
abnormalities and immune complexes were not detected in the
three patients with successful renal transplantation.
Effect of immediate aortic constriction (AC) on sodium (Na) excre-
tion during acute extracellular volume (ECV) expansion in the dog.
N. Lameire, M. A. Waterloos, I. Becaus. S. Ringoir. Nephrological
Division, University Hospital, Ghent, Belgium. Studies in the rat
have indicated that AC prior to expansion of the ECV prevents the
natriuretic response normally seen in this setting. These findings
are taken as evidence against the role for an extra-renal natriuretic
hormone. In order to evaluate this finding in the dog, clearance
studies were performed to compare the effect of AC prior to and
after ECV expansion of 7.5% body weight with 9% saline. Two
groups were studied: I) Delayed clamp studies (N = 7): After
hydropenic clearances, saline was given for 40 minutes, and the
renal perfusion pressure (RPP) was reduced to a mean of 80
mm Hg while the saline was continued. 2) Immediate clamp studies
(N 8): After hydropenic clearances, RPP was decreased to 75
mm Hg followed by saline loading. In both groups, clearance col-
lections were obtained sixty minutes after the initiation of the
saline loading. In group I, total kidney GFR and PAH clearance
remained constant (21.7 vs. 18.8 and 60 vs. 54 mI/mm/kidney;
P > 0.05). Absolute and fractional Na-excretion increased from
29.6 to 63.0 Eq/min (P < 0.05) and from 1.08 to 2.58%, respec-
tively (P < 0.02). In group II, total kidney GFR decreased from
29.9 to 19.9 (P < 0.05), and PAH clearance decreased from 81 to
49 mI/mm/kidney (P < 0.01). However, both absolute and frac-
tional Na excretion increased from 30.1 to 57.1 sEq/min (P< 0.05)
and from 0.80 to 1.85% (P <0.02), respectively. The arterial hema-
tocrit dropped from 43 to 25% (P < 0.01) and from 40 to 26% (P <
0.01) in groups land II, respectively. After release of the AC, frac-
tional Na excretion increased to 10.5% (P < O.OOl)in both groups.
These results indicate that immediate AC does not obviate the
natriuretic response to saline loading in the dog and therefore do
not permit to exclude an extrarenal "natriuretic hormone" as
mediator of the increased natriuresis after acute ECV expansion.
Pharmacokinetics of three aminoglycoside antibiotics: Livido-
mycin, amikacin (BB-K8) and sisomicin in the presence of normal and
impaired renal function. A. Leroy, G. Oksenhendler, J. P. Fillastre,
and G. Humbert. Service de Néphrologie, Hbpital de Boisguillaume,
Bois Guillaume. After a single i.m. injection of 350mg of lividomy-
cm, 7.50 mg/kg of amikacin, or 1 mg/kg of sisomicin, the serum
half-life (T 1/2), in normal subjects was between 1.74 to 2.23 hr.
Eighty to 85% of the injected dose was excreted in urine during
the 24 hours following injection. In uremic patients, serum half-
life (T 1/2) became more prolonged as renal function decreased; it
could reach 40 to 60 hours in very severe uremic patients. Urinary
elimination decreased in correlation with the degree of renal fail-
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ure. In hemodialysed patients, antibiotic concentrations fell from
30 to 60% during an 8-hr session. Based upon these pharmaco-
kinetic data, it is possible to establish dosage schedules adapted to
the degree of renal impairment.
Hyperacute rejection of a transplanted kidney due to a nonimmu-
nological cause. M. Leski, H. Faure, M. VonLanthen, F. Chate-
lanai, J. C. Mu/li, J. Garcia, P. Klouda, A. Spiliopoulos, and P.
Heritier. Hbpital Cantonal, Geneva. A 32-yr-old patient suffering
from a focal glomerular sclerosis, where the differential diagnosis
of PAN has been discussed, underwent a cadaver kidney transplant
on 8/24/76. The 21-yr-old donor had died from a craniae trauma.
There were two HLA identities between the donor and recipient.
No antibodies were found in the recipient, who has never been
transfused. Cross match was negative. Warm ischemia was 38 mm.
Cold ischemia was 18 hr. Because of a leak from the renal vein
appearing when the clamps were removed, it was necessary to
reclamp the renal vessels for more than 5 mm. Diuresis began after
one hour and reached 6.21 over the next 13 hr. Serum creatinine
fell from 8.9 to 1.6 mg/I00 ml over four days. On day six, diuresis
decreased sharply. No urologic cause could be detected. On day
eight, an arteriography showed a typical picture of cortical necro-
sis. On day nine, transplantectomy was performed. The kidney was
large and bluish suggesting a rejection of humoral nature. Surpris-
ingly enough, no immunoglobulins, complement, or fibrinogen
were seen on the immunohistologic examination. Significant circu-
lating antibodies were absent up to several weeks after the trans-
plantectomy. On optic microscopy, the only lesion seen was a
proliferation of the intima of the arteries and arterioles which
provided an explanation for the irreversible ischemia of this kid-
ney. The other kidney from the same donor transplanted in Bale
underwent a similar course. Comparable cases have not been re-
ported in the literature as far as we know. The question is whether
warm ischemia can induce such an anatomo-clinical picture: ex-
cellent function during four days, followed by so-called hyperacute
rejection.
Complement-dependent cytotoxicity induced by anti-glomerular
basement membrane antibodies. Ph. Mahieu, C. Dechenne, and Ph.
Graindorge. Department of Medicine, University of Liege, Belgium.
Antihuman glomerular basement membrane (GBM) antibodies
were obtained by immunization of rabbits with human GBM
glycoproteins mixed with complete Freund's adjuvent. Their spe-
cificity was demonstrated by immunofluoreseent microscopy and
their titer determined by radioimmunoassay. Human glomerular
cells were grown to confluence in 199-Medium containing 20% of
fetal calf serum. Electron microscopy studies demonstrated that
the growing cells were mostly epithelial in origin. The cytotoxie
activity of 25sl antiserum against glomerular cells (about 50,000)
was appreciated in the presence of 25,l of a 1:5 dilution of guinea
pig complement (C). After incubation for 45 mm at 37°C, 0.2%
trypan blue solution was added and viability assessed. In the
presence of control rabbit sera and C, or C alone, at least 90% of
the cells remained viable. In the presence of C and anti-GBM
antibodies, only 10 to 15% of the cells remained viable. No cy-
totoxic effect was observed when positive sera were tested without
C, with heat-inactivated C, or when using fibroblasts as target cells.
Preincubation of anti-GBM antiserum with GBM glycoproteins or
pretreatment of the cells with purified collagenase abolished the
cytotoxic effect. On the contrary, preincubation of the antiserum
with type I collagen or pretreatment of the cells with trypsin did
not significantly reduce the cytolysis. The data suggest that anti-
bodies to GBM glycoproteins elicit C-mediated cytotoxicity, and
that some basement membrane antigens are present at the surface
of the glomerular epithelial cells in culture.
An unusual aspect of kidney tubular basement membrane in
patients with multiple myeloma. L. H. Nol, D. Droz, D. Ganeval,
and P. Jungers. Clinique NCphrologique et INSERM U25, Hôpital
Necker, Paris, France. Renal tissue from 14 patients with multiple
myeloma, Bence-Jones proteinuria, and renal insufficiency was
examined using light, immunofluorescence, and electron micro-
scopy. In four patients an unusual finding was noted in kidney
tubular basement membrane. The distal tubules were pre-
dominantly involved. By light microscopy the tubular basement
membrane was very chromophilic and refringent when stained
with light green, and was argentaffihic. No metachromasia with
violet crystal and no staining with congo red was observed. The
only positive finding using immunofluorescence was a strong fix-
ation of anti-kappa light chain along the tubular basement mem-
branes. By electron microscopy granular and irregular electron-
dense material was located on the external side of the tubular
basement membrane. With higher magnifications no definite struc-
ture could be identified within these deposits. The M-component in
these patients was respectively lgG-kappa, lgA-kappa, and Bence-
Jones-kappa in the two remaining cases. In the other ten patients
this unusual finding in the tubular basement membrane was not
observed. In these patients the light chain was of kappa type in
four and of lambda type in the remaining six. In conclusion, in our
experience, these abnormal peritubular deposits were not observed
in lambda light chain myeloma and seem related to the presence of
kappa light-chain. The morphologic findings suggest deposition of
an abnormal material, immunologically similar to kappa light
chain, rather than a modification of the basement membrane itself
by the M-component. The role of these deposits in the pathogen-
esis of the renal insufficiency will be discussed in regard to the
paucity of the tubular casts in these patients.
Effects of demeclocycline in cirrhotic patients with intractable
ascites and edema. R. Poupon. F. Paillard and F. Darn/s. Service
d'HCpato-Gastro-EniCrologie, hop/ta! Saint-A nroine, and Service
d'Explorations Fonctionnelles, HOp/ta! Tenon, Paris. Demeclocy-
dine (DMC) is known to induce a vasopressin resistant polyuria in
normal subjects and to correct hyponatremia resulting from in-
appropriate secretion of antidiuretic hormone. The drug is thought
to impair the generation and effect of cAMP, the intracellular
mediator of vasopressin action. The aim of this work was to study
the effects of D MC in 5 cirrhotic patients with ascites and edema.
In 3 of these patients the ascites resisted to diuretic therapy.
Throughout the study, fluid and sodium intakes were constant.
After an observation period, the patients were given orally DMC
(1200 mg per day) for ten days. This treatment produced the
following results: 1) Free water clearance became positive in all
patients. Diuresis increased from 300 to 900 mI/24 hr to 1800 to 2500
mI/24 hr. 2) When initially low (127 to 131 mEq/liter), serum
sodium leveled up to values ranging from 135 to 149 mEq/liter. 3)
Urinary sodium output increased from 0 to 15 mEq/24 hr to 40 to
144 mEq/24 hr. 4) In four patients, plasma volume decreased and,
in the same time, blood urea and creatinine increased. 5) When
initially high, plasma renin activity decreased; conversely aldoste-
rone levels increased in four patients. Reinstitution of DMC after
its withdrawal allowed us to observe the same phenomena. Pro-
longed administration of DMC was able to cure patients from as-
cites and edema which previously resisted diuretic therapy. It is
concluded that DMC is able to induce diuresis and natriuresis in
cirrhotic patients with intractable ascites and edema, and might be
useful in the treatment of all sodium and water retention states.
Risks of i.v. administration of formaldehyde to hemodialyzed
patients. R. J. Rkveillaud, A. Deschamps, and Ph. Aubert. Centre
Hospitalier de Saint-Cloud. Formaldehyde (CH2O) in a 2.5% solu-
tiOn is one of the most effective sterilizers for dialyzers. The HF3
and HF4 Dow Cordis capillary kidneys are thus sterilized by intra-
and extra-capillary use of this solution. They must be rinsed before
use with 2 liters of physiologic serum according to the manufac-
turer's directions. A quantitative check is then made with the
"Clinitest" to make sure no (CH2O) is present. This check always
proved negative at our center. However, during the first month of
use, we twice observed the following clinical signs in two patients: a
transitory burning feeling in the vascular region (venous flow), an
uneasy feeling with a smothering sensation and drop in blood
pressure and a strange taste in the mouth. The search for (CH2O)
in the dialysing fluid having proved positive (reaction to chromo-
tropic acid), we had it titrated in the intracapillary compartment
after I, 2, and 3 liters of continuous rinsing and in the extra-
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capillary compartment of the dialysing fluid after 3 liters of rinsing
in a Dow Cordis HF4 dialyser. Blood compartment (venous flow):
I) amount of (CH2O) after one liter of rinsing: in 4 samples out of
13 was 300 to 810 mg/liter. 2) Amount after 2 litres of rinsing: in 5
samples out of 13 was 100 to 220 mg/liter. 3) After 3 litres of
rinsing: in 5 samples out of 11 was 34 to 92 mg/liter. In the fluid
compartment: amount of (CH2O) after 3 litres of rinsing, in 4
samples out of 8, was over 20mg/liter. It appears that ir over one
third of the cases, the residual quantities are great. A possible
chronic toxicity of intravenously administrated (CH2O) may be
feared: neurologic and retinian disturbances, metabolic acidosis,
hemolysis, and antiheparinic action contributory to coagulation
within the capillary fibers. As a result, we believe that with this type
of dialyzer, a 3 litre rising process is necessary and that checking its
effectiveness with the "Clinitest" alone is not sufficient.
Paradoxical hypercalcemia secondary to corticotherapy in a
dialyzed patient with polyvinylpyrrolidone (PVP) thesaurismosis. C.
Richard, E. Dupont, V. Thoua, J.-L. Vanherweghem, P. Potvliege,
D. Verbeelen, C. Toussaint. Département de Nêphrologie et Service
d'Anato,nie Pathologique, Hbpizal (Jniversitaire Brugmann, Bru-
xe//es. In a 36 yr old patient with presumed Wegener's granulo-
matosis, undue administration of 1.5 to 3 kg of PVP (Periston®)
was rapidly followed by irreversible renal failure. After four
months of periodic dialysis, she was transferred to our institution
for transplantation. At this time, the X-ray survey revealed normal
bones. After 12 months of dialysis, an indefinite space-occupying
lesion appeared in the left orbit, leading to exophtalmos, ocular
palsies, and intractable pain. This condition improved dramat-
ically after 10 days of corticotherapy. During the ensuing weeks,
serum calcium rose steadily over 12 mg/dl, with normal serum
parathormone level, and multiple microgeodic lesions appeared in
both humeral upper extremities. Iliac bone biopsy showed heavy
PVP deposits in the reticuloendothelial cells while similar PVP
deposits were observed in peripheral blood macrophages. The
paradoxal hypercalcemia and bone lesions which in this case fol-
lowed corticotherapy could be explained by the action of locally
released lysosomial enzymes.
Acute vasculitis after penicillin therapy: A report of one case with
arteriographic regression of the intrarenal anevrysmal lesions. A.
Vahanian, F. Mignon, A. Chavaz, N. Pauleau, C. He/enon, and G.
Richet. Hbpital Tenon. Paris. The role of drugs in the origin of
acute vasculitis is often discussed. However the regression of the
anevrysmal lesions, notably in the branches of the renal arteries
with steroid therapy in certain conditions has only rarely been
reported. The following observation illustrates such a regression.
One patient, aged 17 yr, was treated by bipenicillin for tonsillitis in
January, 1975. One week later an acute nephritic syndrome ap-
peared, accompanied by numerous extrarenal symptoms, support-
ing the diagnosis of polyarteritis nodosa. Abdominal arteriography
showed numerous intrarenal and hepatic anevrysms. The serious-
ness of his clinical state and the presence of renal failure led to
immediate steroid therapy. Liver, skin, and muscle biopsies did not
permit histologic typing of this acute vasculitis, and a renal biopsy
was not performed because of the intrarenal anevrysms. Six
months later, when steroid therapy was terminated, the clinical
state was satisfactory and renal function was normal. Arteri-
ography showed the disappearance of the intrarenal anevrysms.
However, lesions of the branches of the arteries persisted; these
lesions consisted of irregular or blocked lumens. A year later the
clinical state is stable. After termination of steroid therapy, an
immunoallergic exploration showed a mixed cellular and humoral
sensitivity to penicillin. The lack of definitive histological evidence
does not allow classification of this patient's condition as poly-
arteritis nodosa, although the abundant clinical data and especially
the radiological evidence point to this diagnosis. Regressive evolu-
tion of anevrysmal lesions has already been observed radiologically
and reported in several cases and raises the question of the anatom-
ical nature of the improvement. Many other cases of vasculitis
subsequent to drug administration have been reported, and in the
above case the role of penicillin is very probable but unfortunately
cannot be definitively established.
Prostaglandins (PG) secretion and sodium excretion by the iso-
lated perfused dog kidney. J. L. Vanherweghem, J. Ducobu. A.
d'Hollander, and P. Guerisse. Département di' Nephrologie et Labo-
ratoire de Mèdecine Expérimenta/e, Université Libre de Bruxelles et
Fondation Medicate Reine Elisabeth. Isolated dog kidneys were
simultaneously perfused with heparinized blood on two Nizet's
pump oxygenators; Naproxen (NAP), inhibitor of PG synthesis, is
added to perfusing blood on one side, the other kidney being
studied as control. NAP prevents the vasodilatation which charac-
terized the isolated kidney, without affecting glomerular filtration
rate. Despite the rise in filtered fraction induced by NAP, this
inhibitor decreases tubular sodium reabsorption. This latter effect
is located in the ascending limb of Henle's loop as demonstrated by
decreased CHO/V without changes in CNa + CHo/GRF. PG as-
says showed that NAP induced a 70% decrease in PGF2, synthesis
as compared to control perfused kidneys, without affecting PGE2
levels. Prevention of vasodilatation induced by NAP in the isolated
kidney cannot be explained by inhibition of PGE2 synthesis, al-
though the synthesis of some other vasoactive PG metabolites
could be inhibited. On the other hand, the simultaneous natriuretic
effect and PGF2, synthesis inhibition depicted by NAP would
suggest that PGF2 directly enhances sodium reabsorption in the
ascending limb of Henle's loop.
